Bisphosphonate-related osteonecrosis of the mandible and maxilla: clinical and imaging features

J Comput Assist Tomogr. 2009 May-Jun;33(3):449-54. doi: 10.1097/RCT.0b013e318186b179.

Abstract

Objective: Bisphosphonate-related osteonecrosis of the jaws is a rare, but morbid, condition. We present the clinical and imaging features of 19 patients.

Methods: A review of 19 bisphosphonate-related osteonecrosis patients was performed. Patient demographics, diagnosis, dental procedures, symptoms and clinical findings, location and pattern of involvement, and presence of fractures, sequestra, and fistulae were documented.

Results: Patients included 14 women and 5 men aged 48 to 80 years. Diagnoses included breast carcinoma (n = 11), multiple myeloma (n = 4), osteoporosis (n = 4), prostate carcinoma (n = 2), and lymphoma (n = 1). Seventeen patients received intravenous and 2 received oral bisphosphonates for 2 to 5 years. Bone involvement was noted in the mandible (74%), maxilla (16%), and both (10%). A lytic and sclerotic pattern was most common (58%). Additional findings included fractures (n = 5), sequestra (n = 4), and oroantral fistulae (n = 2).

Conclusions: Bisphosphonate-related osteonecrosis is a rare, but morbid, condition, and imaging features can mimic other conditions. It is important for the radiologist to consider this entity in the appropriate clinical setting.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Bone Density Conservation Agents / adverse effects
  • Diphosphonates / adverse effects*
  • Female
  • Humans
  • Male
  • Mandibular Diseases / chemically induced*
  • Mandibular Diseases / diagnostic imaging*
  • Maxillary Diseases / chemically induced*
  • Maxillary Diseases / diagnostic imaging*
  • Middle Aged
  • Osteonecrosis / chemically induced*
  • Osteonecrosis / diagnostic imaging*
  • Radiography

Substances

  • Bone Density Conservation Agents
  • Diphosphonates